Hepatitis C virus treatment with glecaprevir and pibrentasvir in patients co-prescribed carbamazepine: Three case reports

Table 1 Overview of 3 patients treated with a 12-wk course of carbamazepine whilst co-prescribed carbamazepine for seizure disorders

Patient	Age	Gender	HCV genotype	Treatment-experienced	Cirrhotic	CBZ dose	SVR12
1	43	Female	1b	No	No	300 mg BD	Yes
2	72	Male	1a	No	No	200 mg BD	Yes
3	52	Female	3a	No	No	400/600 mg BD	Yes

HCV: Hepatitis C virus; CBZ: Carbamazepine; SVR 12: Sustained virological response at 12-wk.